Last updated: November 2, 2022
Sponsor: University of Belgrade
Overall Status: Active - Recruiting
Phase
N/A
Condition
Breast Cancer
Cancer
Treatment
N/AClinical Study ID
NCT03516253
VMA-253-18
Ages 45-65 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Histologically confirmed breast cancer,
- Clinical Stadium III and IV,
- Patients able to understand requirements of the study and provide written informedconsent-
Exclusion
Exclusion Criteria:
- Previous radio- or chemotherapy
- Other serious chronic diseases
- Statin therapy
- Use of fat-based dietary supplements (such as fish oil, evening primrose oil etc) 3months prior to study
Study Design
Total Participants: 60
Study Start date:
February 20, 2019
Estimated Completion Date:
June 20, 2024
Study Description
Connect with a study center
Military medical academy
Belgrade, 11000
SerbiaActive - Recruiting
University of Belgrade
Belgrade, 11129
SerbiaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.